Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-year study of MK-0364 in obese patients
2005-002364-29Phase 2Completed
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of taranabant in obesity (3 arms). Primary endpoints: Change in body weight from baseline at Week 52, Proportion of 5% responders at Week 52 and 1 more. Started Jun 2005; status: completed.
02
Drugs
taranabant
03
Conditions
obesity
Beyond the preview
Go deeper on 2005-002364-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002364-29.